A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Inclusion Criteria: * Weight ≥ 50 kilograms (kg), at screening and first admission, and body mass index between 18.0 kilogram per square meter (kg/m\^2) and 32.0 kg/m\^2, inclusive, at screening. * A negative QuantiFERON-TB Gold test result at screening or documentation of a negative result within 3 months before screening. * Normal renal function at screening as evidenced by an estimated glomerular filtration rate (eGFR) ≥ 80 milliliter per minute (mL/min)/1.732 m\^2 calculated with the Chronic Kidney Disease Epidemiology Collaboration formula. Exclusion Criteria: * Any significant acute or chronic medical illness. * Current or recent (within 3 months of study drug administration) gastrointestinal (GI) disease that could impact upon the absorption of study treatment. * GI surgery, including cholecystectomy, that could impact upon the absorption of study treatment, at the investigator's discretion.